Morning Edition · №
Health · Medicine ATHENS, GA.

A Day Without an ICU Pharmacist Raises Death Risk 20%, Study Finds

A multi-institutional study led by the University of Georgia links gaps in critical-care pharmacist coverage, and heavier caseloads, to worse outcomes for intensive-care patients.

SHARE X f in ⧉

Intensive-care patients who go even one day of their stay without care from a clinical pharmacist are 20% more likely to die, according to a multi-institutional study led by researchers at the University of Georgia and published in the journal CHEST. The study also found that risk climbs further as pharmacist workloads grow: patients were 10% more likely to die when a single pharmacist was responsible for more than 15 patients at once, and the odds of death rose roughly 1% for every additional patient added to a pharmacist's caseload.

The findings add to a growing body of research documenting how thin critical-care pharmacist staffing has become at many US hospitals, even as ICU patients increasingly require complex, high-risk medication regimens — vasopressors, sedatives, anticoagulants and antibiotics whose dosing often needs to be adjusted hour by hour. According to a summary of the research from the University of Colorado's Department of Biomedical Informatics, the study drew on staffing and outcomes data across multiple participating hospitals rather than a single institution, strengthening the case that the pattern is not unique to any one health system's circumstances.

Correlation, not yet proof of cause

Researchers and outside reviewers were careful to note the study's limits: the data show an association between pharmacist coverage and mortality, not proof that missed pharmacist visits directly cause patient deaths. Sicker patients, chaotic shifts, or hospitals already under broader staffing strain could independently drive both outcomes, a possibility the authors acknowledge as residual confounding that observational data like this cannot fully rule out. A related multicenter study spanning 64 hospitals in the US, Jordan and Saudi Arabia is examining the same question with more granular staffing and outcomes data collected between August 2023 and January 2025.

Even with those caveats, hospital pharmacy groups have seized on the findings as evidence for an argument they have made for years: that pharmacist staffing in intensive-care units is often treated as discretionary rather than essential, particularly at smaller or rural hospitals that may struggle to justify dedicated ICU pharmacist coverage on cost grounds alone. Whether the study prompts changes to staffing ratios or accreditation standards is likely to depend on how its findings hold up as the larger, multicenter study data matures.

SHARE THIS ARTICLE X Facebook LinkedIn Copy link
Samuel Okafor · Health & Medicine Correspondent

Covers health and medicine for UBStandard: drug approvals, clinical research and the systems that deliver care.

[email protected]
Related coverage Front page →